Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation
Breast cancer is a frequently occurring malignant tumor that is one of the leading causes of cancer-related deaths in women worldwide. Monoclonal antibodies that block programed cell death 1 (PD-1)/programed cell death ligand 1 (PD-L1) – a typical immune checkpoint – are currently the recommended st...
Saved in:
| Main Authors: | Seung-Woo Kim, Chan Woo Kim, Hong Seok Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Animal Cells and Systems |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19768354.2024.2315950 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases
by: Feifei Qiu, et al.
Published: (2025-01-01) -
Inherent PD‐L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis
by: Yoon Jin Cha, et al.
Published: (2025-03-01) -
Biomimetic mesenchymal stem cell membrane-coated nanoparticle delivery of MKP5 inhibits hepatic fibrosis through the IRE/XBP1 pathway
by: Yafei Tian, et al.
Published: (2024-11-01) -
Cytoplasmic HMGB1 promotes the activation of JAK2-STAT3 signaling and PD-L1 expression in breast cancer
by: Ju-Young Han, et al.
Published: (2025-05-01) -
PD-L1 in Breast Cancers and its Prognostic Significance
by: Sayher Kazmi, et al.
Published: (2021-01-01)